Viking Therapeutics Inc (VKTX)
Healthcare
Biotechnology
32.60 $
+2.7%
vs. previous close
Closing price · As of: 3. Aug 2026
Viking Therapeutics Inc (VKTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -279 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.6 | -8.7 | -11 | -15 | -19 | -25 | -22 | -48 | -48 | -73 | -88 | -279 | |
| 0.6 | 1.0 | 1.9 | 1.4 | 0.5 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.4 | |
| 0.0 | 2.6 | 1.8 | 1.5 | 2.6 | 3.7 | 5.8 | 6.1 | 8.7 | 17 | 30 | 41 | |
| -2.2 | 2.6 | 1.8 | 1.5 | 2.6 | 3.7 | 5.8 | 6.1 | 8.7 | – | – | – | |
| 22 | 0.6 | 0.8 | 1.8 | 0.8 | -3.8 | 7.7 | -2.9 | 10 | 3.5 | 9.4 | 49 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -13 | -13 | 3.0 | -1.7 | -266 | 7.5 | 42 | 38 | 55 | -179 | -553 | 341 | |
| – | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -6.8 | -7.1 | -42 | – | |
| 2.5 | -0.1 | -0.1 | -0.1 | -3.8 | – | – | – | – | – | – | – | |
| 2.2 | 22 | 10 | 22 | 300 | 0.9 | 1.0 | 6.9 | 4.2 | 271 | 612 | 76 | |
| 0.6 | 0.0 | 2.3 | 5.9 | 16 | -16 | 21 | -2.7 | 10 | 19 | -29 | 139 | |
| -1.6 | -8.7 | -11 | -15 | -19 | -25 | -22 | -48 | -48 | -73 | -88 | -279 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.